Clinical Care

This insight provides an overview of the key developments witnessed at HIMSS from our teams that were in attendance in Orlando earlier this month. The insight is broken down into four areas of the healthcare technology industry:

The Hospital-at-Home market has received much attention in the wake of the COVID-19 Pandemic as a means to alleviate hospital bed shortages, reduce costs, and improve health outcomes for appropriate patients. Advances in remote patient monitoring technologies and a supportive policy environment offer much promise, but formidable obstacles remain.

The Infusion market has seen various swings in competitive dynamics in recent years. Product recalls, company acquisitions, new product launches, component supply issues and the uptick in demand seen following the COVID-19 pandemic have all had their impact on the market environment. This insight provides a deeper dive into the evolution of the infusion market and subsequent impact on share of the leading players.

The global fetal monitoring market reached $190 million in 2023 and is forecast to rise to $230 million in 2028. This article provides a brief snapshot of some of these major trends.

 The Clinical Care market has seen a plethora of market trends in recent years with the COVID-19 pandemic having the pinnacle effect on growth dynamics and opportunities in most markets. Component and supply issues subsided, and product demand started to rebalance in 2023, as the market adjusted to the newer way in which healthcare is provided. As we head into 2024, many Clinical Care vendors will be seeking opportunities to maximise on the healthcare reset in many regions. This insight discusses the top five trends Signify Research predicts for the Clinical Care market in 2024.

While the spotlight in 2023 shone on developments around Generative Artificial Intelligence (AI), away from the limelight a quiet revolution in AI was taking place, which promises to transform the way we diagnose, manage, and treat cardiovascular diseases, the world’s leading cause of death. Signify Research has just released a deep-dive qualitative analysis of developments around the use of AI to analyse and interpret electrocardiograms (ECGs), one of the world’s most ubiquitous diagnostic tests for cardiac disease.